nach oben

Internal and Emergency Medicine

Erschienen in:

19.08.2019 | IM - Commentary

Telemedicine and decentralized models of care: from anticoagulant monitoring to an expanded concept of vascular medicine

verfasst von: Luca Valerio, Alice Trinchero, Stefano Barco

Erschienen in: Internal and Emergency Medicine | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

Oral anticoagulation is the mainstay therapy for primary and secondary prevention of thromboembolic events in patients with venous thromboembolism (VTE) and atrial fibrillation. After the introduction of direct oral anticoagulants (DOAC), the prevalence of anticoagulated patients in the general population progressively increased [1-4]. This trend will likely continue because of novel indications for anticoagulant treatment, e.g., stable atherosclerotic vascular disease [5], and more accurate risk stratification of patients [6, 7]. …

van den Heuvel JM, Hovels AM, Buller HR, Mantel-Teeuwisse AK, de Boer A, Maitland-van der Zee AH (2018) NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands. Thromb J 16:7. https://doi.org/10.1186/s12959-017-0156-y CrossRefPubMedPubMedCentral

Maura G, Billionnet C, Drouin J, Weill A, Neumann A, Pariente A (2019) Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016. BMJ Open 9(4):e026645. https://doi.org/10.1136/bmjopen-2018-026645 CrossRefPubMedPubMedCentral

Haas S, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Zaghdoun A, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK (2019) Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. J Thromb Haemost. https://doi.org/10.1111/jth.14548 CrossRefPubMed

Zhu J, Alexander GC, Nazarian S, Segal JB, Wu AW (2018) Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017. Pharmacotherapy 38(9):907–920. https://doi.org/10.1002/phar.2158 CrossRefPubMedPubMedCentral

Raschi E, Bianchin M, Fantoni C, Ageno W, De Ponti F, De Ponti R (2017) Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Intern Emerg Med 12(7):923–934. https://doi.org/10.1007/s11739-017-1724-7 CrossRefPubMed

Barnes GD, Kline-Rogers E (2015) Engaging with quality improvement in anticoagulation management. J Thromb Thrombolysis 39(3):403–409. https://doi.org/10.1007/s11239-015-1184-8 CrossRefPubMedPubMedCentral

Testa S, Paoletti O, Zimmermann A, Bassi L, Zambelli S, Cancellieri E (2012) The role of anticoagulation clinics in the era of new oral anticoagulants. Thrombosis 2012:835356. https://doi.org/10.1155/2012/835356 CrossRefPubMedPubMedCentral

Barnes GD, Nallamothu BK, Sales AE, Froehlich JB (2016) Reimagining anticoagulation clinics in the era of direct oral anticoagulants. Circ Cardiovasc Qual Outcomes 9(2):182–185. https://doi.org/10.1161/CIRCOUTCOMES.115.002366 CrossRefPubMedPubMedCentral

Tosetto A, Testa S, Palareti G, Paoletti O, Nichele I, Catalano F, Morandini R, Di Paolo M, Tala M, Esteban P, Cora F, Mannino S, Maroni A, Sessa M, Castaman G (2019) The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02148-7 CrossRefPubMed

10.

Testa S, Alatri A, Paoletti O, Morstabilini G, Medagliani MA, Denti N, Martellenghi E (2006) Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results. Intern Emerg Med 1(1):24–29CrossRef

11.

Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI (2009) Evaluating the impact of study-level factors on warfarin control in US-based primary studies: a meta-analysis. Am J Health Syst Pharm 66(10):916–925. https://doi.org/10.2146/ajhp080507 CrossRefPubMed

12.

Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M, centers participating in the F-S-R, (2017) Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Intern Emerg Med 12(8):1109–1119. https://doi.org/10.1007/s11739-017-1678-9 CrossRefPubMedPubMedCentral

13.

ISTAT_(Italian_Statistical_Bureau) (2019) Aspetti della vita quotidiana—Anno 2018. https://www.istat.it/it/archivio/91926. Rome

14.

Barco S, Granziera S, Coppens M, Douxfils J, Nijkeuter M, Riva N, Vanassche T, Zhang G, Lin M, Kamphuisen PW, Cohen AT, Beyer-Westendorf J (2019) Determinants of the quality of warfarin control after venous thromboembolism and validation of the SAMe-TT2-R2 score: an analysis of Hokusai-VTE. Thromb Haemost 119(4):675–684. https://doi.org/10.1055/s-0039-1678546 CrossRefPubMed

15.

van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968–1975. https://doi.org/10.1182/blood-2014-04-571232 CrossRefPubMed

16.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG (2016) Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Lancet Haematol 3(1):e12–21. https://doi.org/10.1016/S2352-3026(15)00257-4 CrossRefPubMed

17.

Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip GYH (2017) Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Stroke 48(9):2494–2503. https://doi.org/10.1161/STROKEAHA.117.017549 CrossRefPubMed

18.

Burn J, Pirmohamed M (2018) Direct oral anticoagulants versus warfarin: is new always better than the old? Open Heart 5(1):e000712. https://doi.org/10.1136/openhrt-2017-000712 CrossRefPubMedPubMedCentral

19.

Pisters R, Elvan A, Crijns H, Hemels MEW (2018) Optimal long-term antithrombotic management of atrial fibrillation: life cycle management. Neth Heart J 26(6):311–320. https://doi.org/10.1007/s12471-018-1118-0 CrossRefPubMedPubMedCentral

20.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jimenez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M, Ho TPEI (2019) Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz367 CrossRefPubMed

21.

Vinson DR, Mark DG, Chettipally UK, Huang J, Rauchwerger AS, Reed ME, Lin JS, Kene MV, Wang DH, Sax DR, Pleshakov TS, McLachlan ID, Yamin CK, Elms AR, Iskin HR, Vemula R, Yealy DM, Ballard DW, e SIotKPCN (2018) Increasing safe outpatient management of emergency department patients with pulmonary embolism: a controlled pragmatic trial. Ann Intern Med. https://doi.org/10.7326/M18-1206 CrossRefPubMed

22.

Belfiore A, Palmieri VO, Di Gennaro C, Settimo E, De Sario MG, Lattanzio S, Fanelli M, Portincasa P (2019) Long-term management of chronic heart failure patients in internal medicine. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02024-4 CrossRefPubMed

23.

Aaronson EL, Kim J, Hard GA, Yun BJ, Kaafarani HMA, Rao SK, Weilburg JB, Lee J (2019) Emergency department visits by patients with an internal medicine specialist: understanding the role of specialists in reducing ED crowding. Intern Emerg Med 14 (5):777–782. https://doi.org/10.1007/s11739-019-02051-1.CrossRefPubMed

24.

Solvik UO, Lokkebo E, Kristoffersen AH, Brodin E, Averina M, Sandberg S (2019) Quality of warfarin therapy and quality of life are improved by self-management for 2 years. Thromb Haemost. https://doi.org/10.1055/s-0039-1693703 CrossRefPubMed

25.

Kulkarni R (2018) Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. Haemophilia 24(1):33–42. https://doi.org/10.1111/hae.13364 CrossRefPubMed

26.

Heiss C, Madaric J, Belch J, Brodmann M, Mazzolai L (2019) The compelling arguments for the need of medical vascular physicians in Europe. Vasa. https://doi.org/10.1024/0301-1526/a000810 CrossRefPubMed

Titel: Telemedicine and decentralized models of care: from anticoagulant monitoring to an expanded concept of vascular medicine
verfasst von: Luca Valerio
Alice Trinchero
Stefano Barco
Publikationsdatum: 19.08.2019
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 8/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-019-02174-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Telemedicine and decentralized models of care: from anticoagulant monitoring to an expanded concept of vascular medicine

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

Direct oral anticoagulants in factor VII deficiency patient

Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

Vincenzo Tiberio (1869–1915) and the dawn of the antibiotic age

Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia

Left ventricular non-compaction in patients with β-thalassemia: structural remodeling or cardiomyopathy?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin